Thursday, February 22, 2018 1:26:24 PM
Yes, I'm still as confident as ever in Inmed. My confidence stems from their approach, strategy and intellectual property...
1.) They have a world class scientific and management team
2.) They have a bioinformatics database and programs that can steer them to the most promising drug candidates.
3.) They have a patent pending biosynthesis system that can bioidentically create any cannabinoid they need for their drugs. This system can be developed commercially for medical or recreational cannabinoids.
4.) Their focus is cannabinoids, a group of medical compounds that have been unexplored over the years due to ill advised government prohibitions.
5.) They have three drug candidates that are on the verge of clinical trials with more in the pipeline.
These are the reasons I invested originally and why I'm still invested after three+ years.
The company has had quiet stretches several times during that period. It's nothing new and I'm not worried even though I'm just as unhappy as anyone else to see the pps go down.
1.) They have a world class scientific and management team
2.) They have a bioinformatics database and programs that can steer them to the most promising drug candidates.
3.) They have a patent pending biosynthesis system that can bioidentically create any cannabinoid they need for their drugs. This system can be developed commercially for medical or recreational cannabinoids.
4.) Their focus is cannabinoids, a group of medical compounds that have been unexplored over the years due to ill advised government prohibitions.
5.) They have three drug candidates that are on the verge of clinical trials with more in the pipeline.
These are the reasons I invested originally and why I'm still invested after three+ years.
The company has had quiet stretches several times during that period. It's nothing new and I'm not worried even though I'm just as unhappy as anyone else to see the pps go down.
Les
Recent INM News
- InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 04/27/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:58:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:19:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 08:17:05 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:37:48 PM
- InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance • Newsfile • 03/27/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:26 AM
- InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program • Newsfile • 03/23/2026 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
- Sidoti Events, LLC's March Small-Cap Virtual Conference • ACCESS Newswire • 03/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:44 AM
- InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial • Newsfile • 03/09/2026 11:30:00 AM
- InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline • Newsfile • 03/06/2026 10:04:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:58:07 PM
- InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update • Newsfile • 02/11/2026 10:23:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 10:04:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 04:55:06 PM
- InMed Announces Results of 2025 Annual General and Special Meeting • Newsfile • 12/18/2025 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 05:20:20 PM
